MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Motor learning and long duration response to levodopa in Parkinson’s disease.

G. Sciacca, G. Mostile, I. Disilvestro, G. Donzuso, R. Manna, G. Portaro, C. Rascunà, S. Salomone, F. Drago, A. Nicoletti, M. Zappia (Catania, Italy)

Meeting: 2019 International Congress

Abstract Number: 1235

Keywords: Neurophysiology, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Neurophysiology

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To define the role of long-duration response (LDR) in motor learning, evaluating neurophysiological parameters in patients affected by Parkinson’s disease (PD) with and without LDR and undergone or not motor learning skills.

Background: LDR derived from prolonged administration of levodopa in PD [1]. Animal models supported the hypothesis that LDR is implicated in motor learning [2]. P300, motor evoked potentials (MEPs) and Bereitschaftspotential (BP) are neurophysiological tools to quantify motor learning in humans.

Method: Drug-naive PD patients were prospectively enrolled. Patients underwent a 15-day-treatment of levodopa/carbidopa 250/25 mg at 24 h interdose intervals and randomized to perform or not a 15-day motor-training skill. Achievement of LDR was assessed at 15th day of treatment. Patients underwent clinical (Unified Parkinson’s Disease Rating Scale motor section and Hoehn and Yahr stage) and neurophysiological (P300, MEPs and BP) assessments at baseline (T0) and at 15th day of treatment, before taking levodopa (T15).

Results: Thirty PD patients were enrolled: 9 trained patients with a sustained LDR (Group 1), 8 untrained patients with a sustained LDR (Group 2), 7 trained patients without a stable LDR (Group 3) and 6 untrained patients without a stable LDR (Group 4). A statistically significant improvement of P300 latency, MEPs amplitude and early and late BP latencies was observed in Group 1 from T0 to T15 (p<0.006; p<0.03; p<0.02; p<0.002). A statistically significant improvement of early and late BP latencies was observed in Group 2 from T0 to T15 (p<0.001; p<0.005). No significant differences of neurophysiological parameters were found in Group 3 and 4 from T0 to T15.

Conclusion: Our findings support the hypothesis that LDR promote motor learning in PD patients.

References: References 1. Zappia M, Oliveri RL, Montesanti R, Rizzo M, Bosco D, Plastino M, Crescibene L, Bastone L, Aguglia U, Gambardella A, Quattrone A. Loss of long-duration response to levodopa over time in PD: implications for wearing-off. Neurology 1999; 52 (4): 763-767. 2. Beeler JA, Cao ZF, Kheirbek MA, Ding Y, Koranda J, Murakami M, Kang UJ, Zhuang X. Dopamine-dependent motor learning: insight into levodopa’s long-duration response. Ann Neurol 2010; 67(5): 639-647.

To cite this abstract in AMA style:

G. Sciacca, G. Mostile, I. Disilvestro, G. Donzuso, R. Manna, G. Portaro, C. Rascunà, S. Salomone, F. Drago, A. Nicoletti, M. Zappia. Motor learning and long duration response to levodopa in Parkinson’s disease. [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/motor-learning-and-long-duration-response-to-levodopa-in-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/motor-learning-and-long-duration-response-to-levodopa-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley